Navigation Links
BlueFire Ethanol To Present at BIO 2009 International Convention

IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company changing the world's transportation fuel paradigm through the production of ethanol from non-food cellulosic wastes, has announced that the company's President and CEO, Arnold Klann, will participate in a panel discussion titled "From Field to Wheels: What's Going to Work in Biofuels?" on Thursday, May 21 at the BIO 2009 International Convention, the largest global event for the biotechnology industry, which will be held at the Georgia World Congress Center in Atlanta.


The esteemed panelists chosen to participate in the discussion alongside BlueFire CEO Arnold Klann include Harrison Dillon, President and Chief Technology Officer at Solazyme; Kinkead Reiling, Co-Founder and Senior Vice President of Corporate Development at Amyris; Aristides Patrinos, President at Synthetic Genomics, Inc., and moderating the discussion will be Laurence Alexander, Managing Director at Jefferies & Company, Inc.

"BlueFire Ethanol is pleased to participate in this panel discussion with other prominent industry leaders to discuss the viability of the various emerging solutions to the question of what is going to work in biofuels," said Arnold Klann. "BlueFire's cellulosic conversion process provides a commercially-viable method of generating biofuels from a variety of non-food source feedstocks, thereby offering a cost-effective method to offset the import of energy and reduce petroleum consumption. In light of the recently-announced federal support for biofuels initiatives, we are optimistic that technologies such as ours will soon become commercially available and help pave the way towards energy independence."

With the goal of expanding biotech innovations that help "heal, fuel, and feed the world," BIO 2009 International Convention will deliver the partnering tools, licensing tips and other industry resources necessary to meet current economic challenges and to strengthen biotech businesses for the future.

BlueFire Ethanol is currently focused on developing its first ethanol biorefinery in Lancaster, California. The Lancaster facility will use post-sorted cellulosic wastes diverted from landfills in Southern California to produce 3.9 million gallons of fuel-grade ethanol per year. The company was also awarded $40 million from the U.S. Department of Energy for construction of a second plant in Southern California, and has received the first installment of funding from the DOE for the development of the BlueFire Mecca, LLC plant in Southern California.

BIO 2009 International Convention will take place May 18-21, 2009 at the Georgia World Congress Center in Atlanta. For more information or to attend the conference, visit

About BlueFire Ethanol Fuels

BlueFire Ethanol Fuels, Inc. was established to deploy a commercially ready, patented and proven Concentrated Acid Hydrolysis Technology Process for the profitable conversion of cellulosic ("Green Waste") waste materials to ethanol, a viable alternative to gasoline. BlueFire is the only cellulose-to-ethanol company worldwide with demonstrated production of ethanol from urban trash (post-sorted MSW), rice and wheat straws, wood waste and other agricultural residues.

BlueFire is one of four ethanol companies awarded funding from the U.S. Department of Energy to construct ethanol production facilities. Unlike remote corn ethanol production plants, BlueFire's biorefineries will be located in markets with the highest demand for ethanol. This dramatically reduces delivery costs and increases biofuels supply, while providing a unique waste processing technology that helps cities better manage the problem of overflowing landfills. For more information, visit

Forward-Looking Statements

Statements about BlueFire Ethanol, Inc.'s expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. BlueFire's actual results could differ materially from expected results. BlueFire undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; BlueFire will appropriately inform the public.

SOURCE BlueFire Ethanol Fuels, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. President Bill Clinton to Speak at the Ethanol Summit in Brazil
2. Sugarcane Ethanol Industry Eager to Implement U.S. Renewable Fuel Standard
3. Brazils top automakers to distribute 2 million copies of the Ethanol Handbook in partnership with the Brazilian Sugarcane Industry Association
4. New Genomatica Chemical Process Targets Ailing Ethanol Assets
5. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
6. New catalyst paves the path for ethanol-powered fuel cells
7. Panda Ethanols Hereford, Texas Subsidiary Files Voluntary Chapter 11
8. Verenium Announces First Commercial Cellulosic Ethanol Project
9. ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Dartmouth researchers advance cellulosic ethanol production
Post Your Comments:
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... , ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, ... serve as Chief Operating Officer. , Having joined InSphero in November 2013 ... was promoted to Head of InSphero Diagnostics in 2014. There she has built ...
(Date:11/24/2015)... Capricor Therapeutics, Inc. (NASDAQ: ... development and commercialization of first-in-class therapeutics, today announced that ... scheduled to present at the 2015 Piper Jaffray Healthcare ... at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... MUNICH and NEW YORK , ... irst investment by Bristol-Myers Squibb in a ... Bristol-Myers Squibb Company in which the companies ... products in immuno-oncology and other areas of unmet medical need. ... Squibb in LSP 5, the latest LSP fund. This is ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... 29, 2015 Daon, a global leader in ... released a new version of its IdentityX Platform ... North America have already installed IdentityX v4.0 ... a FIDO UAF certified server component as ... activate FIDO features. These customers include some of the ...
(Date:10/29/2015)... , October 29, 2015 ... biometric authentication company focused on the growing mobile ... wallet announces that StackCommerce, a leading marketplace to ... featuring the Wocket® smart wallet on StackSocial for ... ) ("NXT-ID" or the "Company"), a biometric authentication ...
Breaking Biology News(10 mins):